Intranasal delivery of paeoniflorin nanocrystals for brain targeting

Paeoniflorin (PA) is an anti-Parkinson Chinese medicine with inferior bioavailability and difficulty in delivery to the brain. This research is to develop an efficacious PA nanocrystal formulation (PA-NCs) that is suitable for intranasal administration to treat Parkinson's disease (PD). PA-NCs...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Asian J Pharm Sci
Egile Nagusiak: Wu, Chaoyin, Li, Benyue, Zhang, Yi, Chen, Tingting, Chen, Chuangrong, Jiang, Wei, Wang, Qi, Chen, Tongkai
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Shenyang Pharmaceutical University 2020
Gaiak:
Research article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7327772/
https://ncbi.nlm.nih.gov/pubmed/32636950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajps.2019.11.002
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak